MedTrace Logo

Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous

NCT01429701 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2021-02-24

No results posted yet for this study

Summary

Dermatitis eczematous is a recurrent pruritic skin disorder which has a significant morbidity and impaired quality of life due specially pruritus and physical visible skin lesions. The purpose of this trial is evaluate the effectiveness of two different topic associations of drugs.

Conditions

Interventions

DRUG

polymyxin B sulphate + prednisolone + benzocaine + clioquinol

applied 3 times / day at lesion

DRUG

betamethasone + gentamicin + tolnaftato + cleoquinol

applied 3 times / day at lesion

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Principal Investigators

  • Flávia Addór, MD. · Medicin Instituto da Pele

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-06-30
Completion
2012-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01429701 on ClinicalTrials.gov